Prescription drugs such as Invokana can sometimes cause significant complications in patients. Federal safety regulators at the Food and Drug Administration received numerous reports about the serious health risks associated with the diabetes medication Invokana. Patients who suffered from any such health severities can claim for invokana settlements.
Canagliflozin belongs to the class of medications which are categorized as oral antihyperglycemic agents. It is prescribed as part of an overall diabetes management plan which is included along with diet and exercise program. The drug was released in 2013 and got a tremendous response from the patients by 2015.
However, soon there were reports how Invokana and other SGLT2 inhibitor-induced medication caused diabetic ketoacidosis. The condition results from too much acid in the bloodstream and in severe cases, DKA can even lead to coma or death.
Any of the following symptoms should be immediately reported for medical attention:
• Difficulty in breathing
• Abdominal pain
• Unusual fatigue or sleepiness
• Confusion
• Nausea or vomiting
• Abdominal pain
In October 2018, Johnson & Johnson and their subsidiary Janssen settled a large portion of the 1,000 Invokana lawsuits which was in a New Jersey multidistrict litigation (MDL). The lawsuits allege that Invokana caused acute kidney injury, diabetic ketoacidosis, and amputation injuries. The FDA added ketoacidosis warnings to Invokana in June 2016, which is about three years after the drug received approval.
In the invokana settlements, patients claim that the diabetes drug manufacturer failed to warn patients of extreme side effects such as acute kidney failure or risk of lower limb amputation. Many legal claims cite results that Janssen could have done more clinical trials as evidence and studied about the risks of taking Invokana. Instead, the drugmaker promoted the medication to be effective and safe for diabetes patients. In May 2016, the FDA issued an initial safety alert informing the public about the risk. As a result, the FDA required a black box warning be added to the drug label.
If you know someone or have yourself suffered from the complications of invokana, you might be entitled to get the damage awards. Find out from a free and legal consultation from the experts about the lawsuit and how to get a fair settlement in the lawsuit.
Canagliflozin belongs to the class of medications which are categorized as oral antihyperglycemic agents. It is prescribed as part of an overall diabetes management plan which is included along with diet and exercise program. The drug was released in 2013 and got a tremendous response from the patients by 2015.
However, soon there were reports how Invokana and other SGLT2 inhibitor-induced medication caused diabetic ketoacidosis. The condition results from too much acid in the bloodstream and in severe cases, DKA can even lead to coma or death.
Any of the following symptoms should be immediately reported for medical attention:
• Difficulty in breathing
• Abdominal pain
• Unusual fatigue or sleepiness
• Confusion
• Nausea or vomiting
• Abdominal pain
In October 2018, Johnson & Johnson and their subsidiary Janssen settled a large portion of the 1,000 Invokana lawsuits which was in a New Jersey multidistrict litigation (MDL). The lawsuits allege that Invokana caused acute kidney injury, diabetic ketoacidosis, and amputation injuries. The FDA added ketoacidosis warnings to Invokana in June 2016, which is about three years after the drug received approval.
In the invokana settlements, patients claim that the diabetes drug manufacturer failed to warn patients of extreme side effects such as acute kidney failure or risk of lower limb amputation. Many legal claims cite results that Janssen could have done more clinical trials as evidence and studied about the risks of taking Invokana. Instead, the drugmaker promoted the medication to be effective and safe for diabetes patients. In May 2016, the FDA issued an initial safety alert informing the public about the risk. As a result, the FDA required a black box warning be added to the drug label.
If you know someone or have yourself suffered from the complications of invokana, you might be entitled to get the damage awards. Find out from a free and legal consultation from the experts about the lawsuit and how to get a fair settlement in the lawsuit.
